About this document

Nitrosamines in Medicines: Recent Insights by kawthar.raafat11 is a document available to read on EtoBox.

Recent research on nitrosamines, particularly nitrosamine drug substance related impurities (NDSRIs), highlights the complexity and widespread nature of these contaminants in pharmaceuticals. A collaboration among USP, LHASA Limited, AstraZeneca, Sai Life Sciences, and Merck revealed that a significant percentage of active pharmaceutical ingredients (APIs) and their impurities could be potential nitrosamine precursors. Improved analytical methods are being developed to enhance detection and risk assessment,

Author

kawthar.raafat11

Language

EN